Answers are grounded in this paper and cite their sources.
Turner's syndrome is associated with monosomy of the X chromosome and is characterized by female phenotype, short stature, webbed neck, and gonadal dysgenesis. In addition to gonadal dysgenesis, various other congenital malformations have also been associated with the XO chromosomal karyotype, including coarctation of the aorta, horseshoe kidney, and a variety of skeletal abnormalities (1). The presentation of gastrointestinal (GI) bleeding in a patient with Turner's syndrome would often lead to an evaluation for inflammatory bowel disease (IBD) given its association with Turner's syndrome (2,3). Another important but less-recognized cause for GI bleeding in patients with this syndrome is intestinal telangiectasia, first reported by Lisser in 1947 (1). The incidence of intestinal telangiectasias in patients with Turner's has been estimated as about 7% (1,4). We report an adolescent girl with Turner's syndrome who presented with chronic occult GI bleeding requiring chronic transfusion in whom intestinal telangiectasia was diagnosed during laparotomy. This case report will hopefully increase awareness of this condition associated with Turner's syndrome in the pediatric age group and will review the experience with diagnosis and treatment of this condition over the last 50 years. CASE REPORT A 16-year-old female with Turner's syndrome, a recent immigrant from Poland, was referred to the emergency room with a one-week history of pallor and fatigue. There were no other associated symptoms. She denied diarrhea, melena, hematochezia, and abdominal pain. Physical examination was normal except for a webbed neck and pale appearance. There was no abdominal tenderness. Rectal examination revealed tarry black, heme-positive stools. Hemoglobin was 5 g/dl (compared with 14 g/dl two months previously), with a mean corpuscular volume of 78 and reticulocyte count of 2%. Her medical history was significant for multiple hospitalizations in Poland for anemia and transfusions, most recently two years previously. Both she and her family denied any gross GI bleeding in the past. They reported previous upper and lower endoscopies and a bone marrow biopsy in Poland to be normal. Consultation with a hematologist in Poland had led to the understanding that she had a “hemolytic disease” for which she had been followed and chronically transfused as needed varying from every few months to every year. She was diagnosed with Turner's syndrome at age 5, received growth hormone between ages 8 and 14, and has been on estrogen (0.25 mg biweekly) for the past 1.5 years. Her evaluation at this presentation included an upper GI series with small bowel follow-through (UGI with SBFT), repeat esophagogastroduodenoscopy and colonoscopy, all of which were normal. A Meckel's scan primed with cimetidine showed a small focal area of increased tracer in the mid-abdomen. Based on this finding and other negative test results, the patient underwent an exploratory laparotomy. The laparotomy revealed that the patient's entire small bowel serosa was covered with ectatic veins and capillaries (Fig. 1). There were large dilated veins covering the antimesenteric surface of the more proximal small bowel. Biopsies of the small bowel demonstrated abundant transmural ectatic vessels involving the villi, submucosa as well as muscularis mucosa. These vessels stained positively with immunohistochemical markers for CD34. The colon was normal. The pancreas was hard with calcifications present in the head of pancreas. Due to the extensive involvement of small bowel, no intervention was made at the time of the surgery. The patient was started on oral iron supplementation, her hormone therapy was changed to 0.3 mg/d of conjugated estrogen, and she was released. She has maintained a normal hemoglobin without need for transfusion in one year of follow-up.FIG. 1.: Gross specimen of small bowel showing numerous dilated vessels on the serosal surface with occasional tangled networks of worm-like vascular channels.DISCUSSION The vascular lesions found in the small bowel of our patient are similar to those previously reported in association with Turner's, including hemangiomas, telangiectasis, and venous ectasias (4,5,12). Recently, telangiectasis, defined as localized dilation of capillaries and venules have been used to refer more specifically to vascular lesions seen in Turner's syndrome (16). The usual manifestation is intermittent GI bleeding in the form of melena. This is mostly self-limited and responds well to iron treatment (Table 1). Not infrequently, patients may require transfusion and rarely, lesions can cause life-threatening bleeding (8,10,11). Most patients experience their first GI hemorrhage during the first two decades of life (8). Vascular lesions, prone to bleeding, generally regress with age, resulting in improved prognosis after the age of 30 (7,9).TABLE 1: Presentation and clinical course of Turner's patients with gastrointestinal bleedingThe vascular anomalies in Turner's syndrome occur throughout the entire small bowel, large bowel and mesentery, with a preference for the small intestine. The diagnosis is difficult to make because, although all layers of the bowel may be involved, the anomalies are frequently most prominent on the serosal surface, making preoperative detection difficult (Table 2) (8,9,11). Radiological examination of bowel by UGI with SBFT and barium enema are generally not helpful (8,9,11). Only rarely has endoscopy detected dilated blood vessels on the mucosal surface of the duodenum or colon (10,12). For lesions located beyond duodenal segments, small-sized colonoscopes or enteroscopes have been used in adults (16). Angiography was diagnostic in 1 of 4 patients described in the literature and appears to be helpful in identifying larger arteriovenous malformations or hemangiomas, but not the small bowel telangiectasias (Table 2) (8). Vascular lesions might be missed on selective angiography if vasoconstriction occurs, and the yield is lower for small bowel lesions than for colonic (16). Use of newer diagnostic modalities such as magnetic resonance angiography (MRA), including phase-contrast MR venography, which have been used to delineate arterial aneurysms in Behcet disease and colonic variceal veins in portal hypertension, would potentially be helpful in diagnosing the larger vascular lesions of Turner's (18,19). To date, the use of endoluminal high-frequency ultrasonography, a diagnostic method for detecting submucosal vascular malformations of the esophagus and stomach, has not been described with GI vascular ectasia but may be a diagnostic consideration for the future (20).TABLE 2: Diagnostic studies and findingsIt is not uncommon for vascular lesions of the small bowel to be detected through direct inspection of the serosa during laparoscopy or laparotomy (16). The diagnosis of vascular ectasia was made effectively by laparoscopy in one case in the literature and could possibly have made in most of the cases in a similar fashion (8). Explorative laparotomy was chosen for our patient based primarily on the finding of a positive Meckel's scan. Therapies for vascular ectasia have included medical, endoscopic, or surgical options. The mainstay of medical therapy is estrogen supplementation. Estrogen supplementation with or without progesterone has been successful in decreasing bleeding frequency and transfusion requirements in patients with GI telangiectasias including those with Osler-Weber-Rendu syndrome (OWR) (14,21,22). Proposed mechanisms of action of estrogen include increased coagulation with achievement of stasis in microcirculation, trophic effects on the intestinal mucosa or direct stabilizing action on the endothelial lining of the abnormal vessels as has been observed in the GI lesions of hereditary hemorrhagic telangiectasia (16,17,23). Estrogen therapy is commonly initiated in patients with Turner's syndrome and gonadal aplasia at approximately 12 years of age to stimulate the development of female secondary sexual characteristics and to provoke estrogen-withdrawal bleeding. At present, the evidence supporting the use of estrogen therapy to reduce bleeding from venous ectasia is equivocal (14,21–23). Our patient, like a number of others previously reported, had been on estrogen therapy for 1.5 years without prevention of recurrent bleeding (Table 3) (24,25). Recently, octreotide has been successfully used to reduce bleeding from angiodysplasia of the gastrointestinal tract, via reduced splanchnic blood flow (24). There is limited experience with octreotide to date.TABLE 3: Therapeutics and efficacyEndoscopic therapy is usually the initial choice for localized vascular lesions. There are reports of the use and efficacy of electrocautery, argon or Neodymium-Yag laser, heater probe, BICAP or sclerotherapy in the treatment of bleeding vascular formations of the GI tract (16). Endoscopic techniques all rely on visualization and accessibility of the lesion in a limited section of the GI tract and on the presence of single or few individual lesions as opposed to diffuse multiple lesions (16). However, patients with diffuse small bowel telangiectasia often have multiple lesions, many of which are beyond the reach of the endoscope, which makes endoscopic therapy less effective (26). When endoscopic therapy is not possible, surgery may be indicated in patients with severe refractory bleeding. Surgery with intraoperative endoscopy for detection of transmural lesions has more diagnostic and therapeutic value. For some patients in whom the vascular malformations are localized to one segment of the gastrointestinal tract, bowel resection may be performed with good therapeutic results (5,7). In patients with diffuse lesions surgery may offer only temporary palliation. Our patient represents a classic presentation of telangiectasias in Turner's syndrome. Diagnosis was delayed due to the inaccessibility of the small bowel lesions. An additional interesting finding in this case is the calcification of the pancreatic head, likely a result of recurrent local telangiectatic bleeding. Due to the diffuse nature of the lesions in our patient, surgical intervention was not feasible. Medical treatment has provided effective relief from bleeding and will be continued until spontaneous regression occurs with age. The pathogenesis of bowel telangiectasis in Turner's syndrome is unknown. Whether deficiency of an X-chromosome related factor or estrogen deficiency could account for development of these vascular lesions, and why they tend to regress with age is undetermined.
No takes yet. Share an insight, caveat, or question.
Eroğlu et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: